Classification |
Drug |
Tricyclic antidepressants (TCA) |
Tertiary Amine
Secondary Amine
|
Monoamine oxidase inhibitors (MAOI’s) |
Tranylcyclopromine: Non selective MOAI Moclobemide: Selective MOA-A inhibitor |
Selective 5HT reuptake inhibitors (SSRI) |
Fluoxetine Paroxetine Fluvoxamine Sertraline Citalopram Escitalopram |
Serotonin and noradrenalin reuptake inhibitors (SNRI’s) |
Venflaxine Duloxetine |
Selective noradrenaline reuptake inhibitors (NAR’s) |
Reboxetine |
Tetracylcic and unicyclic AD’s |
Mianserin (Tetracyclic) Mirtaxepine (Tetracyclic) Bupropion (Unicyclic) |
5-HT2 Receptor modulators |
Trazodone Vortioxetine |
Circadian rhythym regulators |
Aglomelatine |
Multipotent actions on numerous monoamine receptors which leads to the non-specific increase of 5-HT or NA
The clinical response can take up to 3-5 weeks. This long period can be explained by the effects of the antidepressant drug on the neurotrphic factors. It can take two weeks or longer for the synthesis of neurotrophic factors to take place.
*Look up in textbook and add
|
TAD’s |
SSRI’s |
Efficacy |
Require up titration to minimum effective dosage |
Can immediately start with full dosage administration |
Side effects |
|
|
Safety |
Acute overdose is extremely dangerous and can lead to: coma, convulsions and cardio-toxicity |
Safer to use, fewer side effects |
Tetracyclic Antidepressant. Mirtrazepine primarily blocks a2 receptors which causes an increase in NA(autoreceptors) and 5-HT(heterorecpetors) release.
It also blcoks 5-HT2A (Anti-depressive effects) and blocks 5-HT3 (anxiolytic and decrease nausea).
Additionally it also blocks H1 receptors which leads to sedation and weight gain, and it blocks a1 receptors which can lead to postural hypotension.
Serotonin and noradrenaline reuptake inhibitor. Blocks both 5-HT and NA re-uptake, but has a higher affinity for 5-HT than NA
Circadian rhythm regulator. MT 1 and MT 2 agonist and 5-HT2c antagonist. MT 1 and MT 2 agonism helps in regulation of circadian rhythyms and improves sleep. 5-HT2C antagonism improves sleep through regulation of circadian rhythms and also provides antidepressant action. 5-HT2C antagonism leads to disinhibition of DA and NA release in the frontal cortex, which leads to an increase in Dopamine and NA release.
Brand, L. 2021. Anti-depressants. Study Unit 10. [PowerPoint Presentation]. Study Unit 10, FKLG 312. Potchefstroom, NWU.